Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

[Expression of SDHB, EPAS1 and MIB-1 in Zuckerkandl paragangliomas].

Deng JH, Li HZ, Zhang YS, Xu WF, Cui QC.

Zhonghua Yi Xue Za Zhi. 2012 Nov 27;92(44):3125-7. Chinese.

PMID:
23328423
2.

Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.

Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K.

Endocr Relat Cancer. 2010 Jun 3;17(3):581-8. doi: 10.1677/ERC-10-0004. Print 2010 Sep.

3.

Identification of succinate dehydrogenase-deficient bladder paragangliomas.

Mason EF, Sadow PM, Wagner AJ, Remillard SP, Flood TA, Belanger EC, Hornick JL, Barletta JA.

Am J Surg Pathol. 2013 Oct;37(10):1612-8. doi: 10.1097/PAS.0b013e318293d83c.

PMID:
23797725
4.

Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.

Domingues R, Montalvão P, Magalhães M, Santos R, Duarte L, Bugalho MJ.

J Endocrinol Invest. 2012 Dec;35(11):975-80. doi: 10.3275/8237. Epub 2012 Jan 30.

PMID:
22293219
5.

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.

Comino-Méndez I, de Cubas AA, Bernal C, Álvarez-Escolá C, Sánchez-Malo C, Ramírez-Tortosa CL, Pedrinaci S, Rapizzi E, Ercolino T, Bernini G, Bacca A, Letón R, Pita G, Alonso MR, Leandro-García LJ, Gómez-Graña A, Inglada-Pérez L, Mancikova V, Rodríguez-Antona C, Mannelli M, Robledo M, Cascón A.

Hum Mol Genet. 2013 Jun 1;22(11):2169-76. doi: 10.1093/hmg/ddt069. Epub 2013 Feb 14.

PMID:
23418310
6.

Clinical utility of chromogranin A in SDHx-related paragangliomas.

Zuber S, Wesley R, Prodanov T, Eisenhofer G, Pacak K, Kantorovich V.

Eur J Clin Invest. 2014 Apr;44(4):365-71. doi: 10.1111/eci.12245. Epub 2014 Mar 3.

PMID:
24467715
7.

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C; European-American Paraganglioma Study Group.

JAMA. 2004 Aug 25;292(8):943-51. Erratum in: JAMA. 2004 Oct 13;292(14):1686.

PMID:
15328326
8.

Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.

Oishi Y, Nagai S, Yoshida M, Fujisawa S, Sazawa A, Shinohara N, Nonomura K, Matsuno K, Shimizu C.

Endocr J. 2010;57(8):745-50. Epub 2010 May 25.

9.

A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas.

Maier-Woelfle M, Brändle M, Komminoth P, Saremaslani P, Schmid S, Locher T, Heitz PU, Krull I, Galeazzi RL, Schmid C, Perren A.

J Clin Endocrinol Metab. 2004 Jan;89(1):362-7.

PMID:
14715873
10.

Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations.

Giubellino A, Lara K, Martucci V, Huynh T, Agarwal P, Pacak K, Merino MJ.

Am J Surg Pathol. 2015 Nov;39(11):1488-92. doi: 10.1097/PAS.0000000000000534.

11.

A large deletion in the succinate dehydrogenase B gene (SDHB) in a Japanese patient with abdominal paraganglioma and concomitant metastasis.

Kodama H, Iihara M, Nissato S, Isobe K, Kawakami Y, Okamoto T, Takekoshi K.

Endocr J. 2010;57(4):351-6. Epub 2010 Apr 6.

12.

Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.

Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, Takami H.

Endocr Pathol. 2002 Summer;13(2):149-56.

PMID:
12165664
13.

Phospho-mTOR is not upregulated in metastatic SDHB paragangliomas.

Ghayee HK, Giubellino A, Click A, Kapur P, Christie A, Xie XJ, Martucci V, Shay JW, Souza RF, Pacak K.

Eur J Clin Invest. 2013 Sep;43(9):970-7. doi: 10.1111/eci.12127. Epub 2013 Jul 26.

14.

Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.

Pai R, Manipadam MT, Singh P, Ebenazer A, Samuel P, Rajaratnam S.

APMIS. 2014 Nov;122(11):1130-5. doi: 10.1111/apm.12269. Epub 2014 Apr 16.

PMID:
24735130
15.

Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.

Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW, Pacak K.

J Clin Endocrinol Metab. 2007 Mar;92(3):779-86. Epub 2007 Jan 2.

PMID:
17200167
16.

A novel mutation (P236S) in the succinate dehydrogenase subunit B gene in a Japanese patient with a posterior mediastinal paraganglioma.

Sato H, Shoji S, Kajiwara H, Itoh J, Osamura RY.

Endocr Pathol. 2013 Sep;24(3):144-8. doi: 10.1007/s12022-013-9252-0.

PMID:
23780556
17.

Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.

Tsang VH, Dwight T, Benn DE, Meyer-Rochow GY, Gill AJ, Sywak M, Sidhu S, Veivers D, Sue CM, Robinson BG, Clifton-Bligh RJ, Parker NR.

Endocr Relat Cancer. 2014 May 6;21(3):415-26. doi: 10.1530/ERC-13-0519. Print 2014 Jun.

18.

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.

Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K.

J Clin Endocrinol Metab. 2006 Nov;91(11):4505-9. Epub 2006 Aug 15.

PMID:
16912137
19.

Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.

Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER.

J Clin Endocrinol Metab. 2006 Nov;91(11):4593-8. Epub 2006 Sep 5.

PMID:
16954163
20.

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT, Eisenhofer G.

J Clin Endocrinol Metab. 2008 Dec;93(12):4826-32. doi: 10.1210/jc.2008-1093. Epub 2008 Oct 7.

Supplemental Content

Support Center